070429249 | eavh | 66367206 | | 6946838 | 4/30/2006 12:00:00 am | back pain | | dis | admission date: 12/10/2006 report status:discharge date: 9/9/2006 final discharge orders eberlein , christoper 705-04-21-4rama ry clarkservice: meddischarge patient on: 7/17/06 at 10:00 amcontingent upon not applicablewill d/c order be used as the d/c summary: yesattending: staino , michal n. , m.d.code status:full codedisposition: homedischarge medications:acetylsalicylic acid 81 mg po dailytiazac ( diltiazem extended release ) 360 mg po dailyfood/drug interaction instructionavoid grapefruit unless md instructs otherwise.alert overridden: override added on 8/9/06 bycunas , peter j. , m.d.potentially serious interaction: metoprolol tartrate &diltiazem hcl reason for override: awarebenadryl ( diphenhydramine ) 25 mg po q6hprn itchingdisopyramide-controlled release 300 mg po bidcolace ( docusate sodium ) 100 mg po bidnexium ( esomeprazole ) 40 mg po bidtenex ( guanfacine ) 2 mg po dailyhydroxyzine hcl 25 mg po qidinsulin aspart sliding scale ( subcutaneously ) sc acif bs is less than 125 , then give 0 units subcutaneouslyif bs is 125-150 , then give 2 units subcutaneouslyif bs is 151-200 , then give 3 units subcutaneouslyif bs is 201-250 , then give 4 units subcutaneouslyif bs is 251-300 , then give 6 units subcutaneouslyif bs is 301-350 , then give 8 units subcutaneouslyif bs is 351-400 , then give 10 units subcutaneously andcall ho call ho if bs is greater than 400novolog ( insulin aspart ) 9 units sc acinsulin nph human 50 units sc bidlactulose 30 milliliters po bid prn constipationlevoxyl ( levothyroxine sodium ) 200 mcg po dailylisinopril 20 mg po dailyalert overridden: override added on 10/17/06 bycarther , julius b. , m.d.potentially serious interaction: potassium chloride &lisinoprilpotentially serious interaction: potassium chloride &lisinoprilpotentially serious interaction: potassium chloride &lisinoprilpotentially serious interaction: potassium chloride &lisinopril reason for override: awaretoprol xl ( metoprolol succinate extended release )200 mg po qam food/drug interaction instructiontake consistently with meals or on empty stomach.override notice: override added on 8/9/06 bycoultas , herb e. , m.d.on order for tiazac po ( ref # 266923889 )potentially serious interaction: metoprolol tartrate &diltiazem hcl reason for override: awarenumber of doses required ( approximate ): 4oxycodone 5-10 mg po q4h prn painoxycontin ( oxycodone controlled release ) 10 mg po q12hsenna tablets ( sennosides ) 2 tab po bidtopamax ( topiramate ) 125 mg po tidnumber of doses required ( approximate ): 4zometa ( zoledronic acid ) 2 mg iv monthlydiet: house / ada 2100 cals/dyactivity: walking as toleratedfollow up appointment( s ):dr. benoist , ah 4/12 @ 3pm scheduled ,allergy: nkaadmit diagnosis:back painprincipal discharge diagnosis ;responsible after study for causing admission )back painother diagnosis;conditions , infections , complications , affecting treatment/stayhtn h/o paf converted with nad s/p tah/bso s/p colectomy/stoma/rversaldmoperations and procedures:noneother treatments/procedures ( not in o.r. )mribrief resume of hospital course:cc: back painhpi: 61 yo f with iga lambda multiple myeloma , chronic r lumbar painwho presents with several days of worsening pain. distribution same ,intensity worse; constant. on doa unable to ambulate/bear weight ,limiting ability to care for herself. no trauma , no neuro deficits , noincontinence.in ed: given mso4 , valium , benadrylros: reports qd temp to 101 at home , with sweats , no chills. nolocalizing sx. no wt loss , no appetite. b/l forearm pruritic rash , worsethan baseline annual sun-exposure rash.pmh: mm with iga lambda , sz d/o , htn , dm , chronic back painall: nkdameds: asa , lisinopril , norpace , dilt , toprol , tenex , aranesp , topamax ,levoxyl , nexium , nph 50 bid , iss , zometa qmope: 96.4 89 146/73 18 99% ra. a+o x3 , nad , obese , rrr , ctab , abdsoft w/baseline rlq ttp , mult scars , nabs , guaiac neg with nl tone ,no neuro deficits with 4/5 plantar flexor and hip flexor on r , toesequiv , dtrs 1+ b/l. no bony tenderness , mild ttp over r latparaspinal musculature. neg straight leg raise.labs: k 3.5 , cr 0.9 , ua neg , bld cx negstudies:pelvis and l spine: mild l5-s1 disc space narrowing , no compressionfx , no lytic or blastic lesionsmri: prelim read , l4-5 disc bulging with local nerve root compression ,bone marrow heterogeneity as previously on mri 8/3a: 61 yo f with mm , chronic r lumbar pain here with worsening painlimiting adlscourse:1. neuro: started low dose oxycontin bid with oxycodone for breakthroughpain. no lesions to suggest lesion 2/2 mm. f/u final mri read , but needstrial of medical management , outpatient pt , followed by pain and/orneurosurgical evaluation if still symptomatic.2. heme/onc: iga pending , f/u at gh as scheduled for zometa 4/123. cv: continued extensive list of home antihypertensive medications4. endo: continued home insulin regimen , a1c pending. tsh low at 0.174 ,may need adjusted levoxyl dosing.5. id: no clear source for fevers aside from mm , no source identified onmri , ua/cx or bld cx. afebrile here , unclear if this could be neoplasticversus thermometer error versus operator error.6. derm: pruritic papular rash over b/l upper arms , somewhat like herbaseline annual sun-associated allergy. started atarax , benedryl prn.additional comments: seek medical attention if you notice weakness in your legs , or problemswith bowel or bladder incontinence.your pain medications can cause constipation , use the providedmedications as indicated to avoid this side effect.discharge condition: stableto do/plan:1. f/u with dr. bulkley as scheduled , iga is pending.2. consider pain or neurosurgery evaluation if pain not control with oralpain medications3. f/u a1c , pending4. consider change in levoxyl dose given low tshno dictated summaryentered by: felkel , dwight , m.d. , ph.d. ( qo80 ) 7/17/06 @ 09:40 am end of discharge orders